Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.

Zivadinov R, Dwyer M, Markovic-Plese S, Hayward B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Dangond F, Weinstock-Guttman B.

Ther Adv Neurol Disord. 2015 Mar;8(2):59-70. doi: 10.1177/1756285615572953.

2.

Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly.

Dwyer MG, Zivadinov R, Markovic-Plese S, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Weinstock-Guttman B, Hayward B, Dangond F.

J Neuroimmunol. 2015 Apr 15;281:44-50. doi: 10.1016/j.jneuroim.2015.03.002. Epub 2015 Mar 5.

3.

Genome activation in bovine embryos: review of the literature and new insights from RNA sequencing experiments.

Graf A, Krebs S, Heininen-Brown M, Zakhartchenko V, Blum H, Wolf E.

Anim Reprod Sci. 2014 Sep;149(1-2):46-58. doi: 10.1016/j.anireprosci.2014.05.016. Epub 2014 Jun 6. Review.

PMID:
24975847
4.

Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders.

Hagemeier J, Heininen-Brown M, Gabelic T, Guttuso T Jr, Silvestri N, Lichter D, Fugoso LE, Bergsland N, Carl E, Geurts JJ, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2014 Oct;35(10):1916-23. doi: 10.3174/ajnr.A3969. Epub 2014 May 29.

5.

Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals.

Hagemeier J, Dwyer MG, Bergsland N, Schweser F, Magnano CR, Heininen-Brown M, Ramasamy DP, Carl E, Kennedy C, Melia R, Polak P, Deistung A, Geurts JJ, Reichenbach JR, Zivadinov R.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2144-51. doi: 10.3174/ajnr.A3569. Epub 2013 May 30.

6.

Gray matter SWI-filtered phase and atrophy are linked to disability in MS.

Hagemeier J, Weinstock-Guttman B, Heininen-Brown M, Poloni GU, Bergsland N, Schirda C, Magnano CR, Kennedy C, Carl E, Dwyer MG, Minagar A, Zivadinov R.

Front Biosci (Elite Ed). 2013 Jan 1;5:525-32.

PMID:
23277008
7.

Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy.

Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R.

AJNR Am J Neuroradiol. 2012 Sep;33(8):1596-601. doi: 10.3174/ajnr.A3030. Epub 2012 Mar 29.

8.

Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study.

Hagemeier J, Heininen-Brown M, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Weinstock-Guttman B, Dwyer MG, Zivadinov R.

J Magn Reson Imaging. 2012 Jul;36(1):73-83. doi: 10.1002/jmri.23603. Epub 2012 Mar 7.

PMID:
22407571
9.

Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFN╬▓-1a in multiple sclerosis.

Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B.

Mult Scler. 2012 Aug;18(8):1125-34. doi: 10.1177/1352458511433304. Epub 2011 Dec 22.

PMID:
22194217
10.

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.

Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG.

Neuroimage. 2012 Jan 2;59(1):331-9. doi: 10.1016/j.neuroimage.2011.07.045. Epub 2011 Jul 27.

PMID:
21820063
11.

Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.

Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B, Benedict RH.

J Neurol. 2012 Jan;259(1):139-46. doi: 10.1007/s00415-011-6147-1. Epub 2011 Jul 1.

PMID:
21720932
12.

Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.

Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L, Heininen-Brown M, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):189-95. doi: 10.1136/jnnp.2010.227942. Epub 2010 Nov 3.

PMID:
21047880
13.

Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.

Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F, Zamboni P.

Int Angiol. 2010 Apr;29(2):158-75.

PMID:
20351672

Supplemental Content

Loading ...
Support Center